Ratios Revealed: Decoding Codexis Inc (CDXS)’s Financial Health

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

The closing price of Codexis Inc (NASDAQ: CDXS) was $2.78 for the day, up 9.88% from the previous closing price of $2.53. In other words, the price has increased by $9.88 from its previous closing price. On the day, 1.28 million shares were traded. CDXS stock price reached its highest trading level at $2.81 during the session, while it also had its lowest trading level at $2.575.

Ratios:

Our analysis of CDXS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.10 and its Current Ratio is at 4.18. In the meantime, Its Debt-to-Equity ratio is 0.89 whereas as Long-Term Debt/Eq ratio is at 0.85.

On May 30, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.Cantor Fitzgerald initiated its Overweight rating on May 30, 2024, with a $11 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 13 ’25 when Opaleye Management Inc. bought 85,000 shares for $2.54 per share. The transaction valued at 216,155 led to the insider holds 9,150,000 shares of the business.

Opaleye Management Inc. bought 100,000 shares of CDXS for $261,350 on Mar 06 ’25. The 10% Owner now owns 9,065,000 shares after completing the transaction at $2.61 per share. On Mar 04 ’25, another insider, Opaleye Management Inc., who serves as the 10% Owner of the company, bought 55,000 shares for $2.64 each. As a result, the insider paid 145,398 and bolstered with 8,955,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDXS now has a Market Capitalization of 230287680 and an Enterprise Value of 216724720. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.88 while its Price-to-Book (P/B) ratio in mrq is 3.40. Its current Enterprise Value per Revenue stands at 3.652 whereas that against EBITDA is -4.058.

Stock Price History:

The Beta on a monthly basis for CDXS is 2.36, which has changed by -0.14461541 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, CDXS has reached a high of $6.08, while it has fallen to a 52-week low of $2.47. The 50-Day Moving Average of the stock is -32.75%, while the 200-Day Moving Average is calculated to be -24.54%.

Shares Statistics:

CDXS traded an average of 812.34K shares per day over the past three months and 1332820 shares per day over the past ten days. A total of 81.85M shares are outstanding, with a floating share count of 80.57M. Insiders hold about 2.74% of the company’s shares, while institutions hold 78.21% stake in the company. Shares short for CDXS as of 1740700800 were 3028649 with a Short Ratio of 3.73, compared to 1738281600 on 2955672. Therefore, it implies a Short% of Shares Outstanding of 3028649 and a Short% of Float of 4.0799997999999995.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Most Popular